Vertex Is Down 17% From Its High. The $10B Bet Starts Now.
A rare disease dealmaker just bought its way into a new disease category with $5B in peak revenue potential.
A rare disease dealmaker just bought its way into a new disease category with $5B in peak revenue potential.
The market is pricing in failure. The data is telling a different story.
An 86% EPS beat today just made insurance the most interesting trade in the market.
IBM's warning about enterprise cyber distraction just handed PANW its clearest catalyst yet.
A Meta nuclear PPA and record Q1 adjusted EBITDA are not yet in the price.
A $10B Crinetics deal, a fifth commercial pillar, and Q2 earnings that will define the acquisition thesis.
Record profit, a $265B US bet, and a market asking the wrong question.
A Chapter 11 exit, a GE Aerospace deal, and an AI data center bet that Wall Street is still debating.
A broad Q2 earnings beat is telling a story most investors missed.
AI's heat problem is a $15 billion backlog. Q2 earnings are two weeks away.